RxDoctor Payments Data

Benjamin McCormick

Urology · Salt Lake City, UTNPI 1033506720

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,000 of the $66,924 with a category attached, or 74.7%. Boston Scientific accounts for 78.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $50,000 and has fallen 71.1% since, to $14,460 in 2025. Among urology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,924in general payments, 2019–2025

Across 64 payments — averaging $1045.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$52K
  • Endo USA, Inc.$10K
  • Intuitive Surgical$5K
  • Endo Pharmaceuticals Inc.$420
  • Astellas Pharma US Inc$40
  • Coloplast$21

What the payments were for

  • Consulting fees$8,11012%
  • Speaking & faculty fees$5001%
  • Grants$50,00075%
  • Travel & lodging$2,3243%
  • Food & beverage$2,9894%
  • Education$3,0004%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,924 in reported general payments places this provider in the 95th percentile of 96 urology providers in Utah.

See all urology providers in Utah

Medicare billing

Part B allowed, 2024
$105,918
Medicare patients
130
Services billed
432

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$480
Tamsulosin Hcl11$67

Paid to pharmacies, not to this prescriber.

Other urology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →